MUSTANG BIO, INC. — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Manuel Litchman, M.D., President and CEO, certified the June 30, 2026 quarterly report per SOX 302 and 906, attesting to the accuracy of financial statements and effectiveness of disclosure controls. No material changes to internal controls were disclosed. Litchman continues to serve as Interim Chief Financial Officer, indicating the company has not filled the permanent CFO position.
Why this rating
Standard SOX certification. Interim CFO status suggests leadership gaps but no financial restatement or control failure disclosed. Routine quarterly compliance filing.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.